NanoEcho AB (publ) (STO:NANECH)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0498
-0.0006 (-1.19%)
At close: Apr 24, 2026
Market Cap21.61M -34.8%
Revenue (ttm)487.00K -93.3%
Net Income-15.65M
EPS-0.06
Shares Out433.94M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,897,952
Average Volume2,687,791
Open0.0520
Previous Close0.0504
Day's Range0.0468 - 0.0550
52-Week Range0.0200 - 0.1800
Betan/a
RSI71.03
Earnings DateApr 30, 2026

About NanoEcho AB

NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol NANECH
Full Company Profile

Financial Performance

In 2025, NanoEcho AB's revenue was 487,000, a decrease of -93.30% compared to the previous year's 7.27 million. Losses were -15.65 million, 3.35% more than in 2024.

Financial Statements